Statins and diabetes - Authors' reply

Statins and diabetes - Authors' reply

Bibliografske podrobnosti
Main Authors:	Kearney, P, Keech, A, Simes, J, Collins, R, Baigent, C
Format:	Journal article
Izdano:	2008

Podobne knjige/članki

Statins and diabetes - Reply
od: Kearney, P, et al.
Izdano: (2008)

Safety and efficacy of statins - Authors' reply
od: Collins, R, et al.
Izdano: (2017)

Lessons from the controversy over statins - Authors' reply.
od: Armitage, J, et al.
Izdano: (2016)

Efficacy and safety of cholesterol-lowering treatment - Reply
od: Baigent, C, et al.
Izdano: (2006)

Efficacy and safety of cholesterol-lowering treatment - Reply
od: Baigent, C, et al.
Izdano: (2006)

Benefits of reducing LDL cholesterol among 18,686 patients with diabetes: Meta-analysis of 14 radomized trials of a statin versus control
od: Kearney, P, et al.
Izdano: (2006)

Statins for people at low risk of cardiovascular disease reply
od: Mihaylova, B, et al.
Izdano: (2012)

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.
od: Kearney, P, et al.
Izdano: (2008)

Cholesterol, statins, and mortality - Authors' reply
od: Lewington, S, et al.
Izdano: (2008)

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.
od: Baigent, C, et al.
Izdano: (2005)

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised controlled trials of statins (vol 366, pg 1267, 2005)
od: Baigent, C, et al.
Izdano: (2008)

Statins: are any questions unanswered?
od: Kearney, P, et al.
Izdano: (2006)

Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy.
od: Emberson, J, et al.
Izdano: (2012)

Cholesterol, statins, and mortality - Reply
od: Lewington, S, et al.
Izdano: (2008)

Efficacy and safety of more intensive lowering of LDL cholesterol Reply
od: Baigent, C, et al.
Izdano: (2011)

Efficacy and safety of more intensive lowering of LDL cholesterol Reply
od: Baigent, C, et al.
Izdano: (2011)

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.
od: Mihaylova, B, et al.
Izdano: (2012)

Misrepresentation of statin safety evidence.
od: Armitage, J, et al.
Izdano: (2014)

The authors reply
od: Collins, R, et al.
Izdano: (2009)

Long-term cardiovascular risks and statin treatment impact on socioeconomic inequalities: microsimulation model
od: Wu, R, et al.
Izdano: (2023)

Statin use in low-income and middle-income countries – Authors' reply
od: David Flood, et al.
Izdano: (2022-07-01)

Coxibs and traditional NSAIDs for pain relief - Authors' reply.
od: Bhala, N, et al.
Izdano: (2014)

Larger Effects of Fenofibrate on CVD in Marked Diabetic Dyslipidemia Are Not Explained by Higher Use of Statin Therapy: The FIELD Study
od: Simes, R, et al.
Izdano: (2009)

Blood pressure lowering and cardiovascular risk - Authors' reply.
od: Sundström, J, et al.
Izdano: (2014)

Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy.
od: Cholesterol Treatment Trialists' (CTT) Collaboration, et al.
Izdano: (2012-01-01)

Lifetime effects and cost-effectiveness of statin therapy for older people in the United Kingdom: a modelling study
od: Mihaylova, B, et al.
Izdano: (2024)

Coxibs and traditional NSAIDs for pain relief - Authors' reply.
od: Bhala, N, et al.
Izdano: (2014)

Statins and fracture risk - Reply
od: van Staa, T, et al.
Izdano: (2001)

Authors' reply [5]
od: Chen, Z, et al.
Izdano: (2006)

Effects of Fenofibrate on Cardiovascular (CVD) Events in Patients with Type 2 Diabetes Mellitus (DM) after Adjustment for Statin Use and Other Drugs: the FIELD Study
od: Simes, J, et al.
Izdano: (2008)

Assessing long-term effectiveness and cost-effectiveness of statin therapy in the UK: a modelling study using individual participant datasets
od: Mihaylova, B, et al.
Izdano: (2024)

Authors' reply to Bird.
od: Collins, G, et al.
Izdano: (2012)

Lifetime effects and cost-effectiveness of standard and higher-intensity statin therapy across population categories in the UK: a microsimulation modelling study
od: Mihaylova, B, et al.
Izdano: (2024)

TRIALS OF ANTIPLATELET THERAPY - REPLY
od: Baigent, C, et al.
Izdano: (1994)

Author’s Reply
od: Ashu S Bhalla, et al.
Izdano: (2018-04-01)

Author's Reply
od: R Jain, et al.
Izdano: (2021-01-01)

Authors' reply
od: Heneghan, C, et al.
Izdano: (2012)

The authors reply
od: Jha, P, et al.
Izdano: (2008)

The authors reply
od: Kheifets, L, et al.
Izdano: (2011)

Authors' reply
od: Craddock, N, et al.
Izdano: (2008)